Shares of FibroGen fell by a staggering 56.81% in 30 days from $-36.9 to $19.91 at 19:13 EST on Friday, following last session’s upward trend. NASDAQ Composite is jumping 1.31% to $14,038.76, following last session’s upward trend, This seems, up to now, an all-around positive trend trading session today.

FibroGen’s last close was $19.30, 187.34% under its 52-week high of $57.21.

The company’s growth estimates for the current quarter and the next is 10.1% and 68.4%, respectively.

FibroGen’s Revenue

Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $19.91 at 19:13 EST, way below its 52-week high of $57.21 and higher than its 52-week low of $19.11.

FibroGen’s Moving Average

FibroGen’s value is way below its 50-day moving average of $39.14 and way under its 200-day moving average of $42.31.

More news about FibroGen.


Please enter your comment!
Please enter your name here